Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Active Biotech AB ( (SE:ACTI) ) has provided an update.
Active Biotech AB has announced its Annual General Meeting (AGM) scheduled for May 28, 2025, where shareholders will discuss key resolutions including the re-election of board members and auditors, and the decision to carry forward the company’s accumulated loss without paying dividends. The AGM will also address board remuneration and share issue authorization, reflecting the company’s strategic focus on maintaining financial stability and governance continuity.
More about Active Biotech AB
Active Biotech AB is a Swedish company operating in the biotechnology industry. It focuses on developing pharmaceuticals for the treatment of autoimmune diseases and cancer, aiming to address significant unmet medical needs in these areas.
YTD Price Performance: -21.43%
Average Trading Volume: 26,358
Technical Sentiment Signal: Strong Buy
Current Market Cap: €9.72M
See more insights into ACTI stock on TipRanks’ Stock Analysis page.